Related Experiment Video
Updated: Jan 29, 2026

Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue
Published on: May 17, 2018
Defining the role of the RSK isoforms in cancer
Thibault Houles1, Philippe P Roux2
1Institute for Research in Immunology and Cancer (IRIC), Canada.
Abstract:
The 90kDa ribosomal S6 kinase (RSK) family is a group of Ser/Thr protein kinases (RSK1-4) that function downstream of the Ras/mitogen-activated protein kinase (MAPK) signalling pathway. RSK regulates many substrates involved in cell survival, growth, and proliferation, and as such, deregulated RSK activity has been associated with multiple cancer types. RSK expression and activity are dysregulated in several malignancies, including breast, prostate, and lung cancer, and available evidence suggests that RSK may be a promising cancer therapeutic target. Current limitations include the lack of RSK inhibitors with suitable pharmacokinetics and selectivity toward particular isoforms. This review briefly describes the current knowledge on RSK activation and function, with a particular emphasis on RSK-dependent mechanisms associated with tumorigenesis and pharmacological inhibition.
Insights
The 90kDa ribosomal S6 kinase (RSK) family, crucial for cell growth, is implicated in various cancers. Targeting RSK offers therapeutic potential, but isoform-specific inhibitors are needed.
Area of Science:
- Molecular Biology
- Cell Signaling
- Oncology
Background:
- The 90kDa ribosomal S6 kinase (RSK) family comprises Ser/Thr protein kinases (RSK1-4) functioning downstream of the Ras/MAPK pathway.
- RSK regulates key cellular processes including survival, growth, and proliferation.
- Dysregulated RSK activity is linked to the development and progression of multiple cancer types, such as breast, prostate, and lung cancer.
Purpose of the Study:
- To review current knowledge on RSK activation and function.
- To highlight RSK-dependent mechanisms in tumorigenesis.
- To discuss the potential and challenges of pharmacological RSK inhibition for cancer therapy.
Main Methods:
- Literature review of RSK signaling pathways.
- Analysis of studies linking RSK to cancer development.
- Examination of current and emerging RSK inhibitors.
Main Results:
- RSK plays a significant role in promoting cancer cell survival, growth, and proliferation.
- Aberrant RSK expression and activity are observed across various malignancies.
- RSK is identified as a promising therapeutic target in oncology.
Conclusions:
- Targeting RSK signaling presents a viable strategy for cancer treatment.
- Development of RSK inhibitors with improved pharmacokinetics and isoform selectivity is crucial.
- Further research into RSK-dependent tumorigenesis mechanisms will guide therapeutic development.
Related Concept Videos
Rules for Defining Functions
Piecewise-Defined Functions
Defining Social Psychology
Defining Psychology
Polymers: Defining Molecular Weight
The number average molecular weight (Mn) is the summation of the number...
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...

